Los Angeles Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $274M | Sell |
1,260,942
-1,070,687
| -46% | -$238M | 1.08% | 12 |
|
|
2025
Q4 | $532M | Buy |
2,331,629
+7,343
| +0.3% | +$1.67M | 1.81% | 10 |
|
|
2025
Q3 | $538M | Buy |
2,324,286
+304,281
| +15% | +$62M | 1.83% | 10 |
|
|
2025
Q2 | $375M | Buy |
2,020,005
+451,078
| +29% | +$83.8M | 1.4% | 12 |
|
|
2025
Q1 | $329M | Buy |
1,568,927
+945,165
| +152% | +$184M | 1.45% | 11 |
|
|
2024
Q4 | $111M | Buy |
623,762
+8,264
| +1% | +$1.52M | 0.45% | 52 |
|
|
2024
Q3 | $122M | Buy |
615,498
+382,242
| +164% | +$71.3M | 0.49% | 47 |
|
|
2024
Q2 | $40M | Buy |
233,256
+64,979
| +39% | +$10.8M | 0.14% | 126 |
|
|
2024
Q1 | $30.6M | Sell |
168,277
-147,843
| -47% | -$25.5M | 0.1% | 175 |
|
|
2023
Q4 | $49M | Buy |
316,120
+129,355
| +69% | +$18.9M | 0.18% | 109 |
|
|
2023
Q3 | $27.8M | Sell |
186,765
-8,209
| -4% | -$1.21M | 0.12% | 160 |
|
|
2023
Q2 | $26.3M | Sell |
194,974
-201,509
| -51% | -$29.5M | 0.11% | 163 |
|
|
2023
Q1 | $63.2M | Sell |
396,483
-301,332
| -43% | -$46.1M | 0.28% | 85 |
|
|
2022
Q4 | $113M | Sell |
697,815
-262,465
| -27% | -$40.2M | 0.55% | 45 |
|
|
2022
Q3 | $129M | Sell |
960,280
-267,643
| -22% | -$38.4M | 0.67% | 33 |
|
|
2022
Q2 | $188M | Sell |
1,227,923
-47,277
| -4% | -$7.22M | 0.92% | 21 |
|
|
2022
Q1 | $207M | Buy |
1,275,200
+344,372
| +37% | +$50M | 0.81% | 23 |
|
|
2021
Q4 | $126M | Buy |
930,828
+139,931
| +18% | +$16.5M | 0.47% | 49 |
|
|
2021
Q3 | $85.3M | Sell |
790,897
-118,892
| -13% | -$13.6M | 0.39% | 60 |
|
|
2021
Q2 | $102M | Sell |
909,789
-56,245
| -6% | -$6.33M | 0.45% | 49 |
|
|
2021
Q1 | $105M | Sell |
966,034
-22,116
| -2% | -$2.37M | 0.47% | 39 |
|
|
2020
Q4 | $106M | Sell |
988,150
-175,466
| -15% | -$16.9M | 0.45% | 41 |
|
|
2020
Q3 | $102M | Sell |
1,163,616
-1,245,840
| -52% | -$117M | 0.47% | 42 |
|
|
2020
Q2 | $237M | Buy |
2,409,456
+636,292
| +36% | +$56M | 1.14% | 9 |
|
|
2020
Q1 | $135M | Sell |
1,773,164
-1,892,919
| -52% | -$161M | 0.85% | 18 |
|
|
2019
Q4 | $325M | Buy |
3,666,083
+1,405,797
| +62% | +$117M | 1.62% | 5 |
|
|
2019
Q3 | $171M | Buy |
2,260,286
+1,612,889
| +249% | +$111M | 0.93% | 12 |
|
|
2019
Q2 | $47.1M | Sell |
647,397
-137,189
| -17% | -$10.8M | 0.25% | 97 |
|
|
2019
Q1 | $63.2M | Sell |
784,586
-186,670
| -19% | -$15.3M | 0.35% | 62 |
|
|
2018
Q4 | $89.5M | Buy |
971,256
+337,004
| +53% | +$29.6M | 0.56% | 39 |
|
|
2018
Q3 | $60M | Sell |
634,252
-199,300
| -24% | -$18.9M | 0.31% | 73 |
|
|
2018
Q2 | $77.2M | Sell |
833,552
-87,259
| -9% | -$8.52M | 0.43% | 39 |
|
|
2018
Q1 | $87.2M | Buy |
920,811
+576,810
| +168% | +$63.4M | 0.49% | 37 |
|
|
2017
Q4 | $33.3M | Sell |
344,001
-407,229
| -54% | -$38.4M | 0.18% | 147 |
|
|
2017
Q3 | $66.8M | Buy |
751,230
+10,838
| +1% | +$825K | 0.38% | 62 |
|
|
2017
Q2 | $53.7M | Buy |
740,392
+145,691
| +24% | +$9.79M | 0.34% | 69 |
|
|
2017
Q1 | $38.8M | Buy |
594,701
+201,638
| +51% | +$12.7M | 0.28% | 95 |
|
|
2016
Q4 | $24.6M | Buy |
393,063
+663
| +0.2% | +$40.5K | 0.19% | 155 |
|
|
2016
Q3 | $24.7M | Sell |
392,400
-2,600
| -0.7% | -$168K | 0.21% | 145 |
|
|
2016
Q2 | $24.5M | Sell |
395,000
-22,235
| -5% | -$1.35M | 0.21% | 133 |
|
|
2016
Q1 | $23.8M | Buy |
417,235
+1,235
| +0.3% | +$68.8K | 0.21% | 128 |
|
|
2015
Q4 | $24.6M | Sell |
416,000
-24,610
| -6% | -$1.42M | 0.23% | 120 |
|
|
2015
Q3 | $24M | Buy |
440,610
+6,280
| +1% | +$409K | 0.23% | 129 |
|
|
2015
Q2 | $29.2M | Sell |
434,330
-134,289
| -24% | -$8.77M | 0.27% | 110 |
|
|
2015
Q1 | $33.3M | Sell |
568,619
-105,766
| -16% | -$6.39M | 0.31% | 102 |
|
|
2014
Q4 | $44.1M | Buy |
674,385
+40,537
| +6% | +$2.56M | 0.41% | 72 |
|
|
2014
Q3 | $36.6M | Buy |
633,848
+92,732
| +17% | +$5.15M | 0.44% | 60 |
|
|
2014
Q2 | $30.5M | Buy |
541,116
+58,039
| +12% | +$3.04M | 0.29% | 101 |
|
|
2014
Q1 | $24.8M | Buy |
483,077
+20,451
| +4% | +$1.03M | 0.27% | 110 |
|
|
2013
Q4 | $24.4M | Sell |
462,626
-39,175
| -8% | -$1.93M | 0.27% | 117 |
|
|
2013
Q3 | $22.4M | Buy |
501,801
+106,625
| +27% | +$4.73M | 0.28% | 103 |
|
|
2013
Q2 | $16.3M | Buy |
+395,176
| New | +$17.3M | 0.23% | 123 |
|
Other funds holding ABBV
VCM
VPM
Los Angeles Capital Management's ABBV Position: Q1 2026 in Review
Los Angeles Capital Management reduced its AbbVie (ABBV) stake by 46% in Q1 2026, selling an estimated $238M and leaving 1,260,942 shares worth $274M. The position accounts for 1.08% of the portfolio, ranked #12.
Los Angeles Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $538M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Los Angeles Capital Management held 1,260,942 shares of AbbVie worth $274M as of Q1 2026.
- Los Angeles Capital Management sold 1,070,687 AbbVie shares in Q1 2026, an estimated $238M.
- AbbVie made up 1.08% of Los Angeles Capital Management's portfolio in Q1 2026, its #12 holding.
- Los Angeles Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Los Angeles Capital Management's AbbVie position peaked at $538M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.